Dr Paul Gavin Archives | Cannabiz

Avecho breathes ‘huge sigh of relief’ as early data points to successful CBD insomnia trial

by Steve Jones June 24, 2026June 25, 2026

Avecho Biotechnology has reported positive interim results from its phase III insomnia trial, raising the prospect […]

‘June will be huge’: Avecho boss bullish ahead of CBD trial analysis

by Steve Jones March 26, 2026March 26, 2026

Financial news in brief: Avecho; InhaleRx; Neurotech; Peak; Zelira; Argent

by Adam Sheldon February 2, 2026June 8, 2026

News in brief: Avecho gains key patent allowances; Montu expands medical affairs team

by Adam Sheldon December 9, 2025February 21, 2026

Cannabis executive salaries: who earned what in FY25

by Adam Sheldon October 22, 2025October 22, 2025

News in brief: Shahin becomes Vitura’s largest shareholder; Avecho progresses CBD insomnia trial; Epsilon reports improved cashflow; Zelira locks in R&D loan to advance trial

by Adam Sheldon July 31, 2025July 31, 2025

Avecho advances sleep trial following deal with European pharma giant

by cannabiz team May 20, 2025May 20, 2025

Avecho vision takes shape as CEO flags ‘monster’ OTC opportunity

by Steve Jones March 11, 2025April 29, 2026

Big pharma makes CBD over-the-counter move as Sandoz strikes 10-year deal with Avecho

by Steve Jones March 3, 2025April 29, 2026

Avecho doses first patient in phase III sleep trial

by Martin Lane May 16, 2024July 16, 2024